reason report
bottom line rais estim pt
beat solid initi ebitda growth guidanc
rang addit upsid deal includ mission health
solid beat across board volum price
growth ebitda margin expans initi growth guidanc
ex deal valid strong convict best
breed name pois acceler growth normal
guidanc outsiz share gain tax reform optim capital-expenditure
across servic line improv ambulatori asset level play
field profit peer price growth driven improv
payor mix lead market share posit attract msa capit
deploy offer inorgan growth exist new market
bs solid debt ebitda greater
cap ex plan annual dividend yield
revenu ebitda go mm respect
revenu ebitda acceler mm
addit upsid mission pt move
contempl ev ebitda estim
look forward tenur new ceo hazen outgo ceo
milton johnson close success run quarter
solid revenu ebitda beat strong volum price
growth suppli effici report net revenu
 compar consensu adjust ebitda
mm includ mm one tome malpractic releas vs consensu
mm exhibit
ss adj admiss growth solid outpac peer
see improv demand market well market share
gain expect continu drive volum
admiss ed continu grow
trauma em volum grow respect ss
outpati surgeri trend acceler qoq yoy report
increas volum exhibit
price solid driven improv acuiti servic line
growth potenti remain structur elev level
manag adjust admiss continu solid
ss medicar adj admiss increas ss medicaid
admiss self pay increas exhibit
ev/ebitda
net debt total capit
price-to-earnings lt ep growth
estimate lt ep growth compound-annual-growth-rate
compani inform leerink partner llc research
revenu million bad debt ep present ex one-tim item
pleas refer page import disclosur price chart analyst certif
rais revenu ebitda back solid
rais guidanc midpoint mm mm
vs consensu mm revenu ep guidanc also
rais revis guidanc contempl headwind hurrican
florenc michael exhibit
patient staff safe evacu hurrican michael
florenc impact hca panama citi south carolina
facil estim mm evacu patient
bed gulf coast region medic center panama citi
fl estim facil annual revenu
rais estim initi ebitda growth target
addit upsid pend includ mission health
provid full guidanc januari initi color suggest
ebitda growth continu solid volum growth
revenu ebitda mm reflect solid
medicar inpati rate increas addit
growth post close mission health exhibit
balanc capit deploy opportun aid tax reform
across organ capital-expenditure debt ebitda improv
capital-expenditure consist guidanc normal
cffo mm mm offer potenti
opportunist share buy-back dividend current yield
reiter op increas pt pt
contempl ev ebitda revis estim
though fulli expect posit revis post mission health close
rais estim pt beat solid initi
ebitda growth guidanc rang addit upsid deal includ
solid beat across board volum price growth ebitda margin
expans initi growth guidanc ex deal valid strong convict
best breed name pois acceler growth normal guidanc
outsiz share gain tax reform optim capital-expenditure across servic line improv
ambulatori asset level play field profit peer price growth driven
improv payor mix lead market share posit attract msa capit
deploy offer inorgan growth exist new market
bs solid debt ebitda greater cap ex plan
annual dividend yield revenu ebitda go
mm respect revenu ebitda acceler mm
addit upsid mission pt move contempl ev
ebitda estim look forward tenur new ceo
hazen outgo ceo milt johnson close pit success run quarter
solid revenu ebitda ep report net revenu compar
consensu adjust ebitda mm vs consensu mm ebitda
includ mm adjust profession liabil risk opex ep beat
consensu includ tax benefit due tax cut job act
report solid revenu ebitda ep price vol also
ss adj admiss growth solid outpac peer see improv demand
market well market share gain expect continu drive
volum admiss ed continu grow trauma
em volum grow respect ss outpati surgeri trend acceler
qoq yoy report increas volum
holdingsleerinkconsensusqoqyoynet ebitda bpsd incom net facilityrev/adj admiss bpsadmiss bpsadj admiss bpsss inpati surgeri bpsss outpati surgeri bpser visit bpsexpensessalaries/net bpssupplies/net bpsother expenses/net bpsin mm except per sharereport estimatesfactset consensusreport inc
price solid driven improv acuiti servic line growth potenti
remain structur elev level manag adjust admiss continu solid
ss medicar adj admiss increas ss medicaid admiss
self pay increas
payor mix point commerci volum yoy net exchang
compani report leerink partner llc estim note ss commerci adjust admiss exclud impact exchang
rais revenu ebitda back solid rais
guidanc midpoint mm mm vs consensu mm revenu ep
guidanc also rais revis guidanc contempl headwind hurrican
florenc michael
patient staff safe evacu hurrican michael florenc impact
panama citi south carolina facil estim mm
evacu patient bed gulf coast region medic center panama citi fl
estim facil annual revenu
rais ebitda guidanc midpoint mm mm compar consensu
compani report leerink partner llc research estim note mm
million except per shareiniti guidancerevis estimatesnet ep adjust ss top line growth normal baselin ex-hurricanesmedicar rate increas increas rate mm off-set hurrican michaeloth core trend mm prof liabil changessuppli bp yoy improvementintern uk acquisit savannah ga facil rampok leerink ebitda inc
rais estim initi ebitda growth target addit upsid
pend includ mission health provid full guidanc januari
initi color suggest ebitda growth continu solid volum growth
revenu ebitda mm reflect solid medicar inpati rate
increas addit growth post close mission health
earn call octob felt import give glimps upcom year never predict certainti busi perform environ appear posit gener across market specif respect audio gap plan process finish usual provid detail januari formal issu guidanc year earli look howev indic expect solid volum growth adjust ebitda growth rate somewher within reason rang year current expect full year growth rate samuel hazen presid inc midpoint guidanc right suggest report year-over-year growth well want give percentag obvious yeah want give specif percentag look factor look trend around core growth look capit continu come on-line look turn trend acquisit togeth believ within reason rang year growth rate william rutherford cfo evo inc would like say one thing guidanc clarifi includ acquisit mission milton johnson chairman ceo inc inc
compani report leerink partner llc research estim note mm
consensusleerinkconsensusleerinkconsensusleerinkrevenu expense/net opex/net rev/ per adj inpati admiss adj admin adjust ss top line growth normal baselin ex-hurricanesmedicar rate increas increas rate yoyacquisit acquisit savannah ga facil hurrican yoy impactoth opex core trendswb bp leerink ebitda inc
balanc capit deploy opportun aid tax reform across organ capital-expenditure
 debt ebitda improv capital-expenditure consist guidanc
normal cffo mm mm offer potenti opportunist
share buy-back dividend current yield
growth capital-expenditure
reiter op increas pt pt contempl ev ebitda
revis estim though fulli expect posit revis post mission close
pt contempl ev/ebitda ebitda view
factset compani report leerink partner llc research estim note mm except per share
trade consensu ev/ebitda
factset compani report leerink partner llc research estim note mm except per share
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
base rate outperform price target base
ev/ebitda ebitda view
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
downsid risk leverag
legisl regul cut govern commerci payer reimburs
pressur shift outpati ambulatori set
price target base pro forma ebitda leverag post transact
debt repay
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
delay time sale hospit asset initi improv physician product
exposur larg earn swing result high leverag
variou on-going legal proceed may result cash outflow
pt line takeout price view acquisit like close
next month
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
downsid risk leverag
legisl regul cut government commerci payer reimburs
margin expans headwind class
lack
risk privat equiti takeout merger close
rate outperform price target base combin enterpris
valu ebitda multipl valuat base forward forecast contempl underli
fundament implic sum-of-the-part valuat rang
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
downsid risk leverag
legisl regul cut government commerci payer reimburs
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
point potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level base rate
outperform price target base ev/ebitda
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
acut care segment highli concentr la vega texa
cut govern commerci payer reimburs
declin receiv collect rate
pay mix pressur behavior segment
incom statement mm except provis doubt net expensessalari oper total oper depreci incom ebit net interest pbt incom tax incom yoy incom attribut non-controlling net incom attribut net incom attribut share dilut yoy dilut yoy growth growth expense/net opex/net debt/gross inc
